Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Collins

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Journal of Virology|October 1, 1986
Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodiesK J Coelingh, C C Winter, B R Murphy, et al.
Journal of Virology|October 1, 1987
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunityP R Johnson, R A Olmsted, G A Prince, et al.
Advances in Virus Research|November 5, 1999
Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse geneticsP L Collins, S S Whitehead, A Bukreyev, et al.
Journal of Virology|January 9, 1999
Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivityS S Whitehead, C Y Firestone, R A Karron, et al.
Journal of Virology|July 11, 2000
Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancyA P Durbin, M H Skiadopoulos, J M McAuliffe, et al.
Journal of Virology|January 15, 2003
Virus replication in engineered human cells that do not respond to interferonsD F Young, L Andrejeva, A Livingstone, et al.
Journal of Virology|March 14, 1998
Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypesM H Skiadopoulos, A P Durbin, J M Tatem, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1986
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunityR A Olmsted, N Elango, G A Prince, et al.
Virus Research|April 1, 1994
An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccinesB R Murphy, S L Hall, A B Kulkarni, et al.
Journal of Virology|March 12, 1999
Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzeesS S Whitehead, A Bukreyev, M N Teng, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Journal of Virology|October 1, 1986
Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodiesK J Coelingh, C C Winter, B R Murphy, et al.
Journal of Virology|October 1, 1987
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunityP R Johnson, R A Olmsted, G A Prince, et al.
Advances in Virus Research|November 5, 1999
Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse geneticsP L Collins, S S Whitehead, A Bukreyev, et al.
Journal of Virology|January 9, 1999
Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivityS S Whitehead, C Y Firestone, R A Karron, et al.
Journal of Virology|July 11, 2000
Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancyA P Durbin, M H Skiadopoulos, J M McAuliffe, et al.
Journal of Virology|January 15, 2003
Virus replication in engineered human cells that do not respond to interferonsD F Young, L Andrejeva, A Livingstone, et al.
Journal of Virology|March 14, 1998
Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypesM H Skiadopoulos, A P Durbin, J M Tatem, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1986
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunityR A Olmsted, N Elango, G A Prince, et al.
Virus Research|April 1, 1994
An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccinesB R Murphy, S L Hall, A B Kulkarni, et al.
Journal of Virology|March 12, 1999
Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzeesS S Whitehead, A Bukreyev, M N Teng, et al.
Pageof 16